Why the study?
Does circulating ACE2 activity serve as a biomarker for cardiovascular disease?
Population
Humans, including healthy subjects and those with heart failure, Type 1 diabetes, implantable…
Design
Review
Authors
Loading...
ACE2 activity may indicate CVD risk but should not yet guide practice; leaves open its prognostic value pending large prospective studies.
Does circulating ACE2 activity serve as a biomarker for cardiovascular disease?
Circulating ACE2 activity is an emerging potential biomarker for cardiovascular disease, though large clinical studies are needed to determine its prognostic value.
Patel et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: